REPLIGEN CORP·4

Nov 14, 4:30 PM ET

Hunt Anthony 4

4 · REPLIGEN CORP · Filed Nov 14, 2025

Insider Transaction Report

Form 4
Period: 2025-11-13
Hunt Anthony
Director
Transactions
  • Sale

    Common Stock

    2025-11-13$151.01/sh1,784$269,40298,959 total
  • Sale

    Common Stock

    2025-11-13$152.17/sh2,100$319,55796,859 total
  • Sale

    Common Stock

    2025-11-13$153.14/sh2,923$447,62893,936 total
  • Sale

    Common Stock

    2025-11-13$154.32/sh2,500$385,80091,436 total
  • Sale

    Common Stock

    2025-11-13$155.45/sh3,000$466,35088,436 total
  • Sale

    Common Stock

    2025-11-13$156.22/sh5,737$896,23482,699 total
  • Sale

    Common Stock

    2025-11-13$157.11/sh1,956$307,30780,743 total
  • Exercise/Conversion

    Common Stock

    2025-11-13$33.87/sh+2,952$99,98483,695 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-13+2,95214,760 total
    Exercise: $33.87Exp: 2028-02-29Common Stock (2,952 underlying)
Footnotes (8)
  • [F1]$151.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.53 to $151.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]$152.17 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.57 to $152.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]$153.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.64 to $153.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]$154.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.66 to $154.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]$155.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.78 to $155.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F6]$156.22 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.79 to $156.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F7]$157.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.90 to $157.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F8]14,760 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4